MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- IndoSpace, India's fully integrated supply chain infrastructure services platform, has launched its new logistics…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…
16 September 2025 – Six recipients have received Tech365 Incubate grants, each worth up to USD 40,000, the International Olympic…
August 16, 2025 04:05 ET | Source: Digitalist Group Oyj REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC,…
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…
Spanning over two months, RIO is a combination of a tournament and a leaderboard culminating in an offline finale NEW…
BRADENTON, Fla., Aug. 6, 2025 /PRNewswire/ -- Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the…
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…
June 21, 2025 18:00 ET | Source: BioAge Labs, Inc. Treatment with apelin receptor agonist enhanced glycemic control and demonstrated…